Skip to main content
. Author manuscript; available in PMC: 2011 Oct 24.
Published in final edited form as: J Orthop Res. 2010 Oct;28(10):1330–1337. doi: 10.1002/jor.21126

Figure 5.

Figure 5

Appearance of human (top) and equine (bottom) BMDMSCs in monolayer for each of the 5 different treatment groups stained for alkaline phosphatase on day 14. Human BMDMSCs treated with AdBMP-2 and AdBMP-2/7 demonstrated osteogenic cell morphology compared to other treatment groups. Original magnification, 200x.